Rockville, MD, United States of America

Raphael Lehrer

USPTO Granted Patents = 2 

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 30(Granted Patents)


Location History:

  • Palo Alto, CA (US) (2013)
  • Rockville, MD (US) (2019)

Company Filing History:


Years Active: 2013-2019

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Raphael Lehrer: Innovator in Cancer Treatment

Introduction

Raphael Lehrer is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of cancer treatment, holding 2 patents that focus on individualized therapies for cancer patients.

Latest Patents

Lehrer's latest patents include groundbreaking methods for formulating treatments tailored to individual cancer patients. One patent describes methods to assess genomic and phenotypic differences between cancerous and normal tissues, integrating these results to identify dysfunctional pathways. Another patent focuses on treating melanoma in patients with BRAF mutations who have become resistant to BRAF mutant kinase inhibitors. This method employs inhibitors of multiple receptor tyrosine kinases and outlines ways to identify effective pharmaceutical compositions for these patients.

Career Highlights

Throughout his career, Raphael Lehrer has worked with various organizations, contributing his expertise to advance cancer treatment methodologies. His innovative approaches have garnered attention in the medical community.

Collaborations

Lehrer has collaborated with Robert Coopersmith, enhancing the development of his patented methods and expanding the impact of his work in cancer treatment.

Conclusion

Raphael Lehrer's contributions to cancer treatment through his patents and collaborations highlight his commitment to improving patient outcomes. His innovative methods pave the way for more effective and personalized cancer therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…